Functional consequences of toll-like receptor 4 polymorphisms

Molecular Medicine

Volumn 14, Issue 5-6, 2008, Pages 346-352

  Ferwerda, Bart ^a   McCall, Matthew B B ^a,b   Verheijen, Karlijn ^a   Kullberg, Bart Jan ^a   Van Der Ven, André J A M ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Center for Infectious Diseases ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4;

COMPARATIVE STUDY; EVOLUTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION SENSITIVITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; GENE FREQUENCY; HAPLOTYPES; HUMANS; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 44649115688     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00135.Ferwerda     Document Type: Review

References (77)

1. Akira S, Hemmi H. (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85:85-95.
2. Medzhitov R, Janeway C Jr. (2000) Innate immunity. N. Engl. J. Med. 343:338-44.
3. Kawai T, Akira S. (2006) TLR signaling. Cell Death Differ. 13:816-25.
4. Yarovinsky F, et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-9.
5. Zhang D, et al. (2004) A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-6.
6. Takeda K, Kaisho T, Akira S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21:335-76.
7. Hashimoto C, Hudson KL, Anderson KV. (1988) The Toll gene of Drosophila, required for dorsalventral embryonic polarity, appears to encode a transmembrane protein. Cell 52:269-79.
8. Hoffmann JA. (2003) The immune response of Drosophila. Nature 426:33-8.
9. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-83.
10. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. (1998) A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 95:588-93.
11. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-7.
12. Sultzer BM. (1969) Genetic factors in leucocyte responses to endotoxin: further studies in mice. J Immunol 103:32-8.
13. Sultzer BM. (1968) Genetic control of leucocyte responses to endotoxin. Nature 219:1253-4.
14. Poltorak A, et al. (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24:340-55.
15. Poltorak A, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-8.
16. Schumann RR, et al. (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429-31.
17. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-3.
18. Fenton MJ, Golenbock DT. (1998) LPS-binding proteins and receptors. J. Leukoc. Biol. 64:25-32.
19. O'Neill LA, Greene C. (1998) Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63:650-7.
20. Kim HM, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906-17.
21. Akira S, Takeda K. (2004) Toll-like receptor signaling. Nat. Rev. Immunol. 4:499-511.
22. O'Neill LA, Bowie AG. (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat. Rev. Immunol. 7:353-64.
23. Vogel SN, Fitzgerald KA, Fenton MJ. (2003) TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3:466-77.
24. Miggin SM, O'Neill LA. (2006) New insights into the regulation of TLR signaling. J. Leukoc. Biol. 80:220-6.
25. Mushegian A, Medzhitov R. (2001) Evolutionary perspective on innate immune recognition. J. Cell Biol. 155:705-10.
26. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B. (2000) Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 1:RESEARCH002.
27. Smirnova I, Hamblin MT, McBride C, Beutler B, Di RA. (2001) Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 158:1657-64.
28. Arbour NC, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-91.
29. Schröder NW, Schumann RR. (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5:156-64.
30. Ferwerda B, et al. (2007) TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U. S. A. 104:16645-50.
31. Dahmer MK, Randolph A, Vitali S, Quasney MW. (2005) Genetic polymorphisms in sepsis. Pediatr. Crit. Care Med. 6:S61-73.
32. Read RC, Wyllie DH. (2001) Toll receptors and sepsis. Curr. Opin. Crit. Care 7:371-5.
33. Pasterkamp G, van Keulen JK, de Kleijn DP. (2004) Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur. J. Clin. Invest. 34:328-34.
34. Vink A, de Kleijn DP, Pasterkamp G. (2004) Functional role for Toll-like receptors in atherosclerosis and arterial remodeling. Curr. Opin. Lipidol. 15:515-21.
35. Yang IA, Fong KM, Holgate ST, Holloway JW. (2006) The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr. Opin. Allergy Clin. Immunol. 6:23-8.
36. Van der Graaf CA, Netea MG, Drenth IP, te Morsche RH, Van der Meer JW, Kullberg BJ. (2003) Candida-specific interferon-gamma deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth. J. Med. 61:365-9.
37. Van der Graaf CA, et al. (2006) Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Netw. 17:29-34.
38. Brett PM, et al. (2005) Functional gene polymorphisms in aggressive and chronic periodontitis. J. Dent. Res. 84:1149-53.
39. Folwaczny M, Glas J, Torok HP, Limbersky O, Folwaczny C. (2004) Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin. Exp. Immunol. 135:330-5.
40. Schröder NW, et al. (2005) Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun. 6:448-51.
41. Inoue Y, et al. (2007) CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population. J. Infect. Dis. 195:1618-24.
42. Paulus SC, Hirschfeld AF, Victor RE, Brunstein J, Thomas E, Turvey SE. (2007) Common human Toll-like receptor 4 polymorphisms: role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin. Immunol. 123:252-7.
43. Puthothu B, Forster J, Heinzmann A, Krueger M. (2006) TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis. Markers 22:303-8.
44. Cervera C, et al. (2007) The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 83:1493-500.
45. Ducloux D, et al. (2005) Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int. 67:2454-61.
46. Lorenz E, et al. (2001) Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7:384-7.
47. Palmer SM, et al. (2006) Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin. Transplant. 20:30-6.
48. de Ridder L, et al. (2007) Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm. Bowel Dis. 13:1083-92.
49. Figueroa C, et al. (2006) NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease. Eur. Cytokine Netw. 17:125-30.
50. Ouburg S, et al. (2005) The Toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut 54:439-40.
51. Peeters H, et al. (2007) CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. Int. J. Immunogenet. 34:181-91.
52. Awomoyi AA, et al. (2007) Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J. Immunol. 179:3171-7.
53. Chanock SJ, et al. (2007) Replicating genotypephenotype associations. Nature 447:655-60.
54. Schwartz DA. (2001) The role of TLR4 in endotoxin responsiveness in humans. J. Endotoxin Res. 7:389-93.
55. Schwartz DA. (2001) Inhaled endotoxin, a risk for airway disease in some people. Respir. Physiol. 128:47-55.
56. Schwartz DA. (2002) The genetics of innate immunity. Chest 121:62S-8S.
57. Calvano JE, et al. (2006) Response to systemic endotoxemia among humans bearing polymorphisms of the Toll-like receptor 4 (hTLR4). Clin. Immunol. 121:186-90.
58. Marsik C, Jilma B, Joukhadar C, Mannhalter C, Wagner O, Endler G. (2005) The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin. Chem. 51:2178-80.
59. Schippers EF, van 't Veer C, van Voorden S, Martina CA, le Cessie S, van Dissel JT. (2004) TNF-alpha promoter, Nod2 and Toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 26:16-24.
60. Schippers EF, et al. (2005) IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 29:215-28.
61. Mockenhaupt FP, et al. (2006) Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J. Commun. Dis. 38:230-45.
62. Newport MJ, et al. (2004) The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb.) 84:347-52.
63. Lorenz E, Mira JP, Frees KL, Schwartz DA. (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162:1028-32.
64. Rallabhandi P, et al. (2006) Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J. Immunol. 177:322-32.
65. Kumpf O, Hamann L, Schlag PM, Schumann RR. (2006) Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent Toll-like receptor 4 polymorphisms. Shock 25:123-8.
66. Heesen M, Bloemeke B, Kunz D. (2003) The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotes. Eur. Cytokine Netw. 14:234-7.
67. von Aulock S, et al. (2003) Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J. Infect. Dis. 188:938-43.
68. Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. (2007) Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest. Ophthalmol. Vis. Sci 48:1711-7.
69. Tiberio L, Fletcher L, Eldridge JH, Duncan DD. (2004) Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A. Vaccine 22:1515-23.
70. Kroner A, et al. (2005) Impact of the Asp299Gly polymorphism in the Toll-like receptor 4 (TLR-4) gene on disease course of multiple sclerosis. J. Neuroimmunol. 165:161-5.
71. van der Graaf C, et al. (2005) Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 30:264-8.
72. Fagerås BM, et al. (2004) A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J. Allergy Clin. Immunol. 114:561-7.
73. Erridge C, Stewart J, Poxton IR. (2003) Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signaling. J. Exp. Med. 197:1787-91.
74. Schmitt C, Humeny A, Becker CM, Brune K, Pahl A. (2002) Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin. Chem. 48:1661-7.
75. Norata GD, et al. (2005) Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J. Intern. Med. 258:21-7.
76. Montes AH, et al. (2006) The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis. Clin. Exp. Immunol. 143:404-13.
77. Kinane DF, et al. (2006) Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hyporesponsive to Porphyromonas gingivalis. Genes Immun. 7:190-200.